# Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis

> **NCT02769702** · PHASE4 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 2 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Acthar

## Key facts

- **NCT ID:** NCT02769702
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2017-01-06
- **Final completion:** 2017-01-06
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2018-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02769702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02769702, "Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02769702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*